13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001325083
Total reported value
$179.3M
$179.3M
35 檔
47.7%
In Q4 2024, Knoll Capital Management, LLC's U.S. equity holdings reached a combined market value of $179.3M, distributed across 35 disclosed stock positions.
In Q4 2024, Knoll Capital Management, LLC adopted a defensive or profit-taking posture, trimming 3 positions and completely liquidating 1 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BHVN | Biohaven Ltd. | Stock-Other | 18.28% | -10.93% | +7.04% | |
| 2 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 17.59% | +1.36% | — | |
| 3 | ✓ | Entera Bio LTD | Stock-Other | 8.03% | +2.22% | +51.52% | |
| 4 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 5.98% | — | — | |
| 5 | ALT | Altimmune Inc | Stock-Other | 5.21% | — | — | |
| 6 | GLD | Spdr Gold Shares | ETF-Commodities | 4.99% | — | — | |
| 7 | MGTX | MeiraGTx Holdings plc | Stock-Other | 4.90% | +3.41% | — | |
| 8 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 4.06% | — | — | |
| 9 | OCUL | Ocular Therapeutix Inc | Stock-Other | 3.30% | +3.48% | — | |
| 10 | APLT | Applied Therapeutics Inc | Stock-Other | 3.20% | — | +4.04% | |
| 11 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 2.79% | -1.38% | — | |
| 12 | KGC | Kinross Gold CORP | Stock-Materials | 2.63% | -1.20% | — | |
| 13 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 2.33% | -0.44% | — | |
| 14 | FNV | Franco-nevada CORP | Stock-Materials | 1.89% | -0.67% | — | |
| 15 | EQX | Equinox Gold CORP | Stock-Other | 1.78% | — | — | |
| 16 | SKE | Skeena Resources LTD | Stock-Other | 1.77% | — | — | |
| 17 | MQ8 | Mag Silver CORP | Stock-Other | 1.49% | — | — | |
| 18 | SLV | Ishares Silver Trust | ETF-Commodities | 1.36% | — | — | |
| 19 | BAH | Booz Allen Hamilton Holdings | Stock-Industrials | 1.08% | +2.62% | — | |
| 20 | V | Visa Inc-class A Shares | Stock-Financials | 0.99% | — | — | |
| 21 | PM | Philip Morris International | Stock-Consumer Staples | 0.77% | +0.09% | — | |
| 22 | ITA | Ishares U.s. Aerospace & Def | ETF-Other | 0.72% | +0.10% | — | |
| 23 | NOC | Northrop Grumman CORP | Stock-Industrials | 0.65% | -0.20% | — | |
| 24 | ✓ | Hookipa Pharma | Stock-Other | 0.65% | — | -9.63% | |
| 25 | RGLD | Royal Gold Inc | Stock-Materials | 0.64% | -1.58% | — | |
| 26 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.59% | — | — | |
| 27 | DEO | Diageo Plc-sponsored Adr | Stock-Consumer Staples | 0.55% | — | — | |
| 28 | AGI | Alamos Gold Inc-class A | Stock-Materials | 0.49% | -0.38% | — | |
| 29 | WPM | Wheaton Precious Metals CORP | Stock-Materials | 0.45% | -0.13% | — | |
| 30 | NEWP | New Pacific Metals CORP | Stock-Other | 0.37% | -0.02% | — | |
| 31 | SIL1EUR | Silvercrest Metals Inc | Stock-Other | 0.35% | — | — | |
| 32 | CRDL | Cardiol Therapeutics Inc-a | Stock-Other | 0.08% | -0.07% | EXIT | |
| 33 | ✓ | Orgenesis, Inc. | Stock-Other | 0.06% | -0.01% | -20.24% | |
| 34 | GRAL | Grail Inc | Stock-Healthcare | — | — | — | |
| 35 | IRD | Opus Genetics Inc | Stock-Other | — | — | -99.95% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Entera Bio LTD | +4.6% | +51.52% | Add |
| 2 | ALDX | Aldeyra Therapeutics Inc | +3.9% | — | Unchanged |
| 3 | VRNA | Verona Pharma PLC - Adr | +3.3% | — | Unchanged |
| 4 | MGTX | MeiraGTx Holdings plc | +2.5% | — | Unchanged |
| 5 | ALT | Altimmune Inc | +2% | — | Unchanged |
| 6 | BHVN | Biohaven Ltd. | +1.8% | +7.04% | Add |
| 7 | GLD | Spdr Gold Shares | +1.4% | — | Unchanged |
| 8 | OCUL | Ocular Therapeutix Inc | +0.9% | — | Unchanged |
| 9 | AEM | Agnico Eagle Mines LTD | +0.7% | — | Unchanged |
| 10 | KGC | Kinross Gold CORP | +0.7% | — | Unchanged |
| 11 | SKE | Skeena Resources LTD | +0.5% | — | Unchanged |
| 12 | FNV | Franco-nevada CORP | +0.5% | — | Unchanged |
| 13 | ✓ | Avadel Pharmaceuticals PLC ADR | +0.4% | — | Unchanged |
| 14 | MQ8 | Mag Silver CORP | +0.4% | — | Unchanged |
| 15 | V | Visa Inc-class A Shares | +0.4% | — | Unchanged |
| 16 | SLV | Ishares Silver Trust | +0.3% | — | Unchanged |
| 17 | EQX | Equinox Gold CORP | +0.2% | — | Unchanged |
| 18 | PM | Philip Morris International | +0.2% | — | Unchanged |
| 19 | ITA | Ishares U.s. Aerospace & Def | +0.2% | — | Unchanged |
| 20 | RGLD | Royal Gold Inc | +0.2% | — | Unchanged |
| 21 | NOC | Northrop Grumman CORP | +0.1% | — | Unchanged |
| 22 | DEO | Diageo Plc-sponsored Adr | +0.1% | — | Unchanged |
| 23 | BAH | Booz Allen Hamilton Holdings | +0.1% | — | Unchanged |
| 24 | WPM | Wheaton Precious Metals CORP | +0.1% | — | Unchanged |
| 25 | MREO | Mereo Biopharma Group Pl-adr | +0.1% | — | Unchanged |
| 26 | SIL1EUR | Silvercrest Metals Inc | +0.1% | — | Unchanged |
| 27 | NEWP | New Pacific Metals CORP | 0% | — | Unchanged |
| 28 | GRAL | Grail Inc | — | — | Unchanged |
| 29 | CRDL | Cardiol Therapeutics Inc-a | 0% | — | Unchanged |
| 30 | IRD | Opus Genetics Inc | -0.1% | -99.95% | Trim |
| 31 | ✓ | Orgenesis, Inc. | -0.1% | -20.24% | Trim |
| 32 | SEA1EUR | Seabridge Gold Inc | -0.1% | — | Unchanged |
| 33 | CVS | Cvs Health CORP | -0.4% | EXIT | Sold out |
| 34 | ✓ | Hookipa Pharma | -2.7% | -9.63% | Trim |
| 35 | AGI | Alamos Gold Inc-class A | -3.6% | — | Unchanged |
| 36 | APLT | Applied Therapeutics Inc | -18.8% | +4.04% | Add |
According to official SEC Form 13F filings, Knoll Capital Management, LLC reported a total U.S. public equity portfolio value of $179.3M across 35 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BHVN, ALDX, ENTERA BIO LTD) accounted for 47.7% of total reported equity market value during Q4 2024.
Top Position Liquidated / Trimmed
CVS
前期市值: $911.8K
During Q4 2024, Knoll Capital Management, LLC's top holdings by market value included BHVN (18.3%)、ALDX (17.6%)、ENTERA BIO LTD (8.0%). The largest single position, BHVN, represented 18.3% of total portfolio value.
In Q4 2024, Knoll Capital Management, LLC made 7 total portfolio adjustments, initiating 0 new buys, adding to 3 positions, trimming 3 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.